Results 51 to 60 of about 4,166,301 (304)

Going viral − Virus‐targeting nanobodies for research, diagnostics and therapy

FEBS Letters, EarlyView.
The increasing prevalence of viral diseases represents a major threat for global human health. Nanobodies, small binding fragments derived from camelid heavy‐chain antibodies, offer versatile tools for viral research, diagnostics, and antiviral therapy.
Domenic Ebert, Ulrich Rothbauer
wiley   +1 more source

KNOWLEDGE, ATTITUDE AND PRACTICE AMONG HEALTHCARE PROFESSIONALS TOWARDS ADR REPORTING IN ABBOTTABAD PAKISTAN

International Journal of Pharmacy & Integrated Health Sciences, 2021
Background: Healthcare professionals can play an important role in reporting adverse drug reactions as it is a global health problem and required to be addressed.
doaj   +1 more source

Table of adverse drug reactions.

, 2019
Table of adverse drug reactions.
Oliver Sartor (4102138), Kevin B. Knopf (7109324), Ashley Godwin (7109300), Y. Tony Yang (3170937), Henry C. Ausdenmoore (7109306), Terence Young (7109321), William J. Hrushesky (7109312), Paul R. Yarnold (7109318), Bartlett J. Witherspoon (7109297), Brian Chen (149932), Charles L. Bennett (329817), Matthew A. Taylor (7109294), Jayanth Vemula (7109303), Benjamin Schooley (7109291), James O. Armitage (7109309), John Restaino (7109315), Henrik S. Thomsen (494716)   +16 more
core   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

Molecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura, Tadahiro Kuribayashi, Johannes Brägelmann, Sachi Okawa, Masataka Taoka, Shunta Mori, Tomoka Nishimura, Takaaki Tanaka, Go Makimoto, Kiichiro Ninomiya, Kammei Rai, Eiki Ichihara, Ryohei Katayama, Katsuyuki Hotta, Masahiro Tabata, Yosuke Togashi, Yoshinobu Maeda, Martin L. Sos, Katsuyuki Kiura, Kadoaki Ohashi   +19 more
wiley   +1 more source

Development and inter-rater reliability of the Liverpool adverse drug reaction causality assessment tool. [PDF]

, 2011
To develop and test a new adverse drug reaction (ADR) causality assessment tool (CAT)
Smyth, RL, Williamson, PR, Gallagher, RM, Turner, MA, Kirkham, JJ, Nunn, AJ, Bird, KA, Mason, JR, Pirmohamed, M   +8 more
core  

Serum tryptase levels in adverse drug reactions

, 1997
We evaluated the usefulness of individual tryptase levels and variations after adverse drug reactions in 64 patients. Our aim was to find a tool for the diagnosis of drug allergy.
Prieto, Alicia, Tornero, Pilar, Ordoqui, Elena, Aranzábal, Ascención, Herrero, Teresa, Zubeldia Ortuño, José Manuel, Rodríguez, Vicente, Baeza, María Luisa, Rubio, María   +8 more
core   +1 more source

Preoperative circulating tumor cells integrated with imaging analysis for prognostic evaluation in head and neck squamous cell carcinoma

Molecular Oncology, EarlyView.
Detecting circulating tumor cells (CTCs) in blood before surgery may help predict outcomes in patients with head and neck squamous cell carcinoma (HNSCC). Here, we show when combined with tumor size and lymph node involvement from routine imaging, CTC status identifies high‐risk patients with poorer survival—offering a simple, minimally invasive tool ...
Susanne Flach, Gizem Abaci, Tom Huberty, Axel Lechner, Lukas Käsmann, Jens Ricke, Sophia Stöcklein, Martin Canis, Philipp Baumeister, Marianna Alunni‐Fabbroni   +9 more
wiley   +1 more source

Adverse drug reactions

Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul, 1999
It has been established that drugs can’t be useful without causing side effects at the same time. There are many different variables contributing the development of these adverse effects, such as pharmaceutical (Change in the main effective substance of ...
AA Moghadam Nia
doaj  

Adverse cutaneous drug reaction

Indian Journal of Dermatology, 2008
In everyday clinical practice, almost all physicians come across many instances of suspected adverse cutaneous drug reactions (ACDR) in different forms. Although such cutaneous reactions are common, comprehensive information regarding their incidence, severity and ultimate health effects are often not available as many cases go unreported. It is also a
Nayak Surajit, Acharjya Basanti
openaire   +3 more sources

Epigenetic silencing of the liver‐specific lncRNA LUNAR promotes liver cancer progression via NOTCH activation

Molecular Oncology, EarlyView.
LUNAR is a liver‐specific long noncoding RNA (lncRNA) that is highly expressed in normal liver but becomes epigenetically silenced in hepatocellular carcinoma through promoter hypermethylation. Loss of LUNAR is associated with NOTCH activation, epithelial–mesenchymal transition, and metastasis, whereas restoring LUNAR restrains metastatic progression ...
Se Ha Jang, Hyung Seok Kim, Geum Ok Baek, Moon Gyeong Yoon, Su In Lee, Jee‐Yeong Jeong, Ji Eun Han, Soon Sun Kim, Jae Youn Cheong, Jung Woo Eun   +9 more
wiley   +1 more source